Anna has launched 13 products in oncology and rare diseases. She had direct P&L responsibility for global, European and individual country businesses. She built a successful European biotech business...
Edward is a senior oncology drug development consultant based in Cambridge, MA.
Christine is a clinical drug developer with more than 25 years of experience in large pharma companies.
Colin G. Miller
Colin is a recognized expert in medical imaging. He has spent much of his recent career providing consultancy to biotech and pharma companies developing novel pharmaceuticals.
William (Bill) Slichenmyer
Bill is a clinical drug developer and medical oncologist with more than 20 years’ experience in the biopharma industry.
Stuart has significant experience of the life science and medical device industries, with 25 years of global work experience in the USA, Europe, Japan, China and Australasia.
Simon has more than two decades of experience managing and advising on strategic and product development issues.
Rob co-founded Alacrita in 2009 and opened Alacrita’s US office in Cambridge, Massachusetts in 2012. He provides business development, valuation and licensing support to biotech and pharma companies.
Anthony leverages 12 years of building and managing a biotechnology company together with more than 18 years as a management consultant to the pharma and biotechnology industries.